Drug Topics
MAY 24, 2024
Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.
Pharmacy Times
MAY 24, 2024
The role of semaglutide as a glucagon-like peptide-1 (GLP-1) receptor antagonist could offer further treatment options to improve patient outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 24, 2024
In an abstract presented at Digestive Disease Week 2024, researchers analyzed Clostridioides difficile episodes and identified the risk factors and potential medications that caused them.
STAT
MAY 24, 2024
A new study published Friday provides more evidence of the potential danger of drinking unpasteurized, or raw, milk containing H5N1 avian flu viruses. The work , published in the New England Journal of Medicine, showed that mice that were fed milk from H5N1-infected cows became very ill.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 24, 2024
Experienced litigation lawyer Mark Cuker sat down with Drug Topics to discuss pharmacy benefit managers and their often corrupt practices.
Pharmacy Times
MAY 24, 2024
Multiple states have enacted legislation to rein in PBM practices
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 24, 2024
Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population. Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new re
Pharmacy Times
MAY 24, 2024
As medical cannabis use grows, pharmacist involvement is essential.
Fierce Healthcare
MAY 24, 2024
A range of digital health companies today are harnessing natural language processing in different ways to catch those at risk and direct them to resources.
PharmaVoice
MAY 24, 2024
The stage is set for potential blockbuster-level showdowns targeting these high-growth indications.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 24, 2024
A new federal lawsuit challenging the Biden administration’s new minimum nursing home staffing rule lays out the worst-case scenario: Hundreds of long-term care facilities forced to downsize or close, tens of thousands of vulnerable seniors displaced, and countless others waiting longer for care. Not only that, the complaint argues that the Centers for Medicare and Medicaid Services lacked the authority to implement the final rule.
Fierce Pharma
MAY 24, 2024
While it’s hard to overstate the success Novo Nordisk’s GLP-1 franchise has already achieved, the company’s latest deep dive into semaglutide data in chronic kidney disease (CKD) could help set a n | Early Friday, Novo shared full, positive results from the FLOW trial assessing the ability of once-weekly semaglutide 1.0 mg to help combat major kidney outcomes such as kidney failure, loss of kidney function and death from kidney or cardiovascular causes in people with Type 2 diabetes and chronic
Pharmacy Times
MAY 24, 2024
By venturing beyond the traditional, you can not only shape your own fulfilling career, but also contribute to the future of pharmacy practice and improve patient care for generations to come.
STAT
MAY 24, 2024
The MDMA study was her last hope. She had read headlines celebrating a 83% response rate in one small, early study of the psychedelic for treating PTSD, and was counting on the new clinical trial to alleviate her own post-traumatic stress disorder. Instead, after her first MDMA session, she felt intense despair when her symptoms didn’t dissipate.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 24, 2024
Speakers at the 2024 Society of Pain and Palliative Care Virtual Conference discussed advanced treatment opportunities for patients with substance use disorder (SUD) and cancer-related pain.
pharmaphorum
MAY 24, 2024
Exciting advancements in the world of clinical trials - Arecor Therapeutics, Faron, AstraZeneca, Volta Medical, J&J, Pneumagen, and Nimbus Therapeutics make headlines. Dive into this week's top stories impacting the future of medicine.
STAT
MAY 24, 2024
It’s an honor to fill in for Ed Silverman this morning. There is only one Pharmalot, but when he’s out, his fellow STAT coffee and tea drinkers step in to make sure your morning cup of pharma news is uninterrupted. It’s Friday, the last workday before the long Memorial Day weekend here in the U.S. (and so we’ll next land in your inbox Tuesday).
pharmaphorum
MAY 24, 2024
AffyImmune Therapeutics has recorded what it says is the first documented complete response in a patient with a solid tumour treated with CAR-T therapy. The case comes from a phase 1 study of its ICAM-1 targeting CAR-T autologous candidate AIC100 in patients with relapsed/refractory poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC), which will be reported at the ASCO congress next week.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 24, 2024
About one-third of Americans who reach age 65 will need nursing home care in their lifetimes — which can be a daunting thought if you recall the suffering of residents as the Covid-19 pandemic exposed long-standing problems in nursing homes. These problems did not fade away with the end of the public health emergency, and nursing home residents continue to be disproportionately affected by Covid-19.
pharmaphorum
MAY 24, 2024
NICE and NHS England are seeking feedback on proposed new rules and commissioning principles for medtech products.
STAT
MAY 24, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we see some holes in the data for MDMA-assisted therapy, and ponder how that might impact the FDA’s upcoming decision over its approval. Also, the agency’s advisers debate Guardant’s colon cancer liquid biopsy test, and we see new data showing Ozempic’s efficacy in preventing death in diabetes and chronic kidney diseas
pharmaphorum
MAY 24, 2024
Shares in Merus spike on ASCO abstract on phase 2 trial of EGFRxLGR5 bispecific petosemtamab in head and neck cancer.
STAT
MAY 24, 2024
During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.
The Guardian - Pharmaceutical Industry
MAY 24, 2024
Obesity prevention is cheaper long-term option, says Cambridge professor, with focus on dietary advice and exercise plans Skinny jabs risk being used as a cop-out by governments to avoid making hard policy choices to prevent obesity, a leading expert has warned. Prof Giles Yeo, a geneticist at the University of Cambridge and expert on obesity and the brain control of food intake, said drugs such as semaglutide – the active ingredient in the weight-loss jab Wegovy – were remarkable and worked for
pharmaphorum
MAY 24, 2024
This week’s round-up of biotech financings is led by a $120 million round for UK-based antibody-drug conjugate (ADC) developer Pheon, with SixPeaks also pulling in nine figures and smaller rounds for Progentos, LabGenius, and Grey Wolf, and Imvax.
The Checkup by Singlecare
MAY 24, 2024
You’ve heard that mixing medications can be dangerous. But when you have a nagging cough that’s keeping you up all night, it can be tempting to try a second treatment if the first doesn’t work. NyQuil , which contains acetaminophen , dextromethorphan, and doxylamine , is a popular over-the-counter (OTC) cough medicine and cold remedy that you probably already have in your medicine cabinet.
Fierce Pharma
MAY 24, 2024
In a change of pace from the recent COVID-related business struggles for Pfizer, the drugmaker has picked up a valuable reward from the FDA in the form of a priority review voucher (PRV). | The FDA awarded the voucher based on Paxlovid's status as a countermeasure to a material medical threat, according to a notice in the Federal Register.
Pharmaceutical Technology
MAY 24, 2024
The US FDA's EMDAC is set to hold a meeting to assess the benefit-risk profile of Novo Nordisk's insulin icodec, to treat type 1 diabetes.
The Checkup by Singlecare
MAY 24, 2024
Hydroxychloroquine is a generic prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat malaria, rheumatoid arthritis, and erythematosus lupus. It’s also sold under the brand name Plaquenil. Hydroxychloroquine is considered a first-line treatment for autoimmune inflammatory conditions such as lupus. It’s been shown to reduce lupus flare-ups and help prevent long-term damage from flares.
European Pharmaceutical Review
MAY 24, 2024
UCB has announced positive results from the first Phase III trials evaluating the efficacy and safety of an IL-17A and IL–17F inhibitor to treat adults with moderate-to-severe hidradenitis suppurativa. Humanised IgG1 monoclonal antibody (mAb) BIMZELX ® (bimekizumab-bkzx) selectively binds to IL-17A, IL-17F, and IL-17AF cytokines. This inhibits their interaction with the IL-17RA/IL-17RC receptor complex, UCB explained.
The Checkup by Singlecare
MAY 24, 2024
Azithromycin ( brand name Zithromax ) is a commonly used antibiotic that treats a broad spectrum of bacterial infections in cats, including skin infections, upper respiratory tract infections , pneumonia, bronchitis, and blood infections. Its use in cats is “off-label,” meaning that the U.S. Food and Drug Administration ( FDA ) has not approved the drug for use in companion animals.
Fierce Healthcare
MAY 24, 2024
Elevance Health's philanthropic arm is launching a new initiative that aims to provide loans to small businesses and other organizations in a bid to address health equity. | Elevance Health's philanthropic arm is launching a new initiative that aims to provide loans to small businesses and other organizations in a bid to address health equity.
The Checkup by Singlecare
MAY 24, 2024
Meloxicam is a prescription drug originally branded under the name Mobic. As a nonsteroidal anti-inflammatory drug (NSAID), it is prescribed for moderate to severe pain experienced from disorders such as osteoarthritis, rheumatoid arthritis, or juvenile rheumatoid arthritis. It may also be used in ankylosing spondylitis. Meloxicam is unique from other over-the-counter NSAID options in that it follows a different metabolic pathway that is less harmful to the gastrointestinal system.
Expert insights. Personalized for you.
528 
Let's personalize your content